Planta Med 2009; 75(2): 142-145
DOI: 10.1055/s-0028-1088390
Pharmacology
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Protective Effect of 4-Methoxy-5-hydroxycanthin-6-one, A Natural Alkaloid, on Dextran Sulfate Sodium-Induced Rat Colitis

Jun-Feng Liu1 , 3 , Meng Shao2 , 3 , Da-Wei Zhai3 , Ke Liu4 , Li-Jun Wu1
  • 1School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Liaoning, P. R. China
  • 2College of life Science, Jilin University, Jilin, P. R. China
  • 3Shandong Target-drug Research Co., Ltd., Shandong, P. R. China
  • 4School of Pharmacy, Yantai University, Shandong, P. R. China
Further Information

Publication History

Received: May 12, 2008 Revised: September 29, 2008

Accepted: October 6, 2008

Publication Date:
15 December 2008 (online)

Abstract

In the present study, we evaluated the effect of 4-methoxy-5-hydroxycanthin-6-one (CAN), a natural alkaloid isolated from Picrasma quassioides (D.Don) Benn., on ulcerative colitis induced by dextran sulfate sodium (DSS) in rats in comparison with the positive control drug, sulfasalazine (SASP). Given orally for several days, CAN significantly reduced the severity of colitis and mitigated changes in colon length, colon mucosa myeloperoxidase (MPO) activity, and the level of tumor necrosis factor-α (TNF-α) in serum. The effect of CAN was similar to that of SASP. These results suggest that CAN treatment might be an effective therapeutic intervention against ulcerative colitis induced by DSS.

Abbreviations

CAN:4-methoxy-5-hydroxycanthin-6-one

DSS:dextran sulfate sodium

IBD:inflammatory bowel disease

MPO:myeloperoxidase

SASP:sulfasalazine

TNF-α:tumor necrosis factor-α

UC:ulcerative colitis

References

  • 1 Podolsky D K. Inflammatory bowel disease.  N Engl J Med. 2002;  347 417-29
  • 2 Egger B, Bajaj-Elliott M, MacDonald T T, Lnglin R, Eysselein V E, Buchler M W. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency.  Digestion. 2000;  62 240-8
  • 3 Cooper H S, Murthy S NS, Shah R S, Sedergran D J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.  Lab Invest. 1993;  69 238-49
  • 4 Pharmacopoeia of China, Part I. Beijing; Chemical Industry Press 2005: 139
  • 5 Chen M, Fan H Y, Dai S J, Liu K. Alkaloids from twigs and leaves of Picrasma quassioides. .  Chin Tradit Herb Drugs. 2007;  6 807-10
  • 6 Yang J X. Picrasma quassioides (D.Don) Benn. In: Song ZY, editor. Modern research of traditional Chinese herbs.  Beijing: Beijing Medical University & Beijing Union Medical College. Press;  1996 498-522
  • 7 Sung Y IK, Koike K, Nikaido T, Ohmoto T, Sankawa U. Inhibitors of cyclic AMP phosphodiesterase in medicinal plants. V. Inhibitors of cyclic AMP phosphodiesterase in Picrasma quassioides Bennet, and inhibitory activities of related β-carboline alkaloids.  Chem Pharm Bull. 1984;  32 1872-7
  • 8 Ohmoto T, Sung Y IK, Koike K. Effect of alkaloids of simaroubaceous plants on the local blood flow rate.  Shoyakugaku Zasshi. 1985;  39 28-34
  • 9 Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.  Gastroenterology. 1990;  98 694-702
  • 10 Mahler M, Bristol I J, Leiter E H, Workman A E, Birkenmeier E H, Elson C O. et al . Differential susceptibility of inbred mouse strain to dextran sulfate sodium-induced colitis.  Am J Physiol. 1998;  274 544-51
  • 11 Wirtz S, Neufert C, Weigmann B, Neurath M F. Chemically induced mouse models of intestinal inflammation.  Nat Protoc. 2007;  2 541-6
  • 12 Morris G P, Beck P L, Herridge M S, Depew W T, Szewczuk M R, Wallace J L. Hapten-induced model of chronic inflammation and ulceration in the rat colon.  Gastroenterology. 1989;  96 795-803
  • 13 Rachmilewitz D, Simon P L, Schwartz L W, Griswold D E, Fondacaro J D, Wasserman M A. Inflammatory mediators of experimental colitis in rats.  Gastroenterology. 1989;  97 326-37
  • 14 John D. Chinese Herbal, Part V. Shanghai; Scientific & Technical Publishers 1999: 13-6
  • 15 D′Haens G. Anti-TNF therapy for Crohn’s disease.  Curr Pharm Des. 2003;  9 289-294
  • 16 Murata Y, Ishiguro Y, Itou J. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.  J Gastroenterol. 1995;  30 56-60
  • 17 Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.  Clin Exp Immunol. 1999;  116 238-45
  • 18 Krawisz J E, Sharon P, Stenson W F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity.  Gastroenterology. 1984;  87 1344-50
  • 19 Porter S N, Howarth G S, Butler R N. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitis rats.  Scand J Gastroenterol. 1998;  33 967-74

Prof. Dr. Li-Jun Wu

School of Traditional Chinese Medicine

Shenyang Pharmaceutical University

Shenyang 110016

People’s Republic of China

Phone: +86-24-2398-6481

Fax: +86-24-2398-6481

Email: wulijun_111@hotmail.com

>